Literature DB >> 9554813

Contribution of endothelin to the acute pressor response of L-NAME in stroke-prone spontaneously hypertensive rats.

J Fink1, N Y Fan, L Rosenfeld, C T Stier.   

Abstract

In this study, we examined whether endothelin (ET) plays a role in the short-term increase in mean arterial pressure (MAP) after nitric oxide synthase (NOS) inhibition with N(omega)-nitro-L-arginine methyl ester (L-NAME) in stroke-prone spontaneously hypertensive rats (SHRSPs). Experiments were performed by using Inactin-anesthetized male SHRSPs that were pretreated with chlorisondamine to block reflex autonomic cardiovascular effects. Injection of L-NAME (10 mg/kg, i.v.), but not D-NAME, produced rapid and marked increases (74 +/- 3 mm Hg) in MAP that were sustained for >1 h. In SHRSPs that were treated with the ET(A/B) receptor antagonist, L-754,142 (15 mg/kg + 15 mg/kg/h), L-NAME increased MAP by 45 +/- 4 mm Hg (p < 0.0001 compared with L-NAME alone). L-754,142 blocked pressor responses to big ET-1 by >90% but was without effect on pressor responses to norepinephrine. Plasma levels of ET-1 averaged 5 +/- 1 pg/ml in animals given vehicle and were slightly increased in animals given either L-NAME alone (7 +/- 2 pg/ml) or L-754,142 alone (7 +/- 2 pg/ml) but increased markedly when L-NAME and L-754,142 were given together (114 +/- 18 pg/ml). This may relate to an effect of L-754,142 to block ET-receptor-mediated clearance of ET-1. We conclude that ET plays a role in the short-term pressor response after NOS inhibition in SHRSPs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9554813     DOI: 10.1097/00005344-199804000-00022

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  4 in total

1.  Regorafenib induces rapid and reversible changes in plasma nitric oxide and endothelin-1.

Authors:  Nilka de Jesus-Gonzalez; Emily Robinson; Radostin Penchev; Margaret von Mehren; Michael C Heinrich; William Tap; Qian Wang; George Demetri; Suzanne George; Benjamin D Humphreys
Journal:  Am J Hypertens       Date:  2012-07-12       Impact factor: 2.689

2.  Irisin Lowers Blood Pressure by Improvement of Endothelial Dysfunction via AMPK-Akt-eNOS-NO Pathway in the Spontaneously Hypertensive Rat.

Authors:  Jinjuan Fu; Yu Han; Jialiang Wang; Yukai Liu; Shuo Zheng; Lin Zhou; Pedro A Jose; Chunyu Zeng
Journal:  J Am Heart Assoc       Date:  2016-10-26       Impact factor: 5.501

3.  Effect of Lutein on L-NAME-Induced Hypertensive Rats.

Authors:  Ji Hoon Sung; Young Soo Jo; Su Jin Kim; Jeong Soo Ryu; Myung Chul Kim; Hyun Ju Ko; Sang Soo Sim
Journal:  Korean J Physiol Pharmacol       Date:  2013-07-30       Impact factor: 2.016

Review 4.  Acute nitric oxide synthase inhibition and endothelin-1-dependent arterial pressure elevation.

Authors:  Robert M Rapoport
Journal:  Front Pharmacol       Date:  2014-04-01       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.